5+

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to "train young men and women able and eager to create and put into action such ideas, methods, techniques and information". The Institute is a dream come true of its founder late Mr G.D.Birla - an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Originally Gujarat based Company presence of 35 years in Pharma formulation having own marketing setup as well as 3rd party/loan licence activity at Gujarat and Dehradun plant.

Post: Assistant Manager- Q.A.

Optimal environment to natural, personal and professional development leading to the making of responsible citizens. The day begins in the holy and spiritual environment with a prayer. Complete discipline, unfitness and the unity brought to be attained thought a dress code for staff members and students.

Recognising the high incidence of tuberculosis around Dharmasthala, a modern TB Sanatorium was established at Laila under the aegis of the Shri Dharmasthala Manjunatheshwara Medical Trust. Now it has been turned into a general hospital since April 2003 as private institutions are not allowed to treat tuberculosis patients.

KlinEra has been partnering with pharmaceutical, biotech and device companies since 1999, providing innovative and customized clinical services to their client’s. Today, a decade’s presence in the Clinical Research Arena has made it a mature, comprehensive, creditworthy clinical research organization with offices in Mumbai, India and in San Jose, CA, USA.

Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine.